Abstract
There is a growing interest in transcatheter therapies for tricuspid regurgitation (TTVR), with several dedicated systems in development. Contemporary outcomes of bioprosthetic tricuspid valve replacement (TVR) surgery can be used as a benchmark for TTVR until randomized trials in the field are
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
